inclusion criteria: - positive sars-cov-2 diagnostic test (rt-pcr or rapid antigen test)at screening - has symptoms consistent with mild or moderate covid-19, as determined by the investigator, with onset ≤5 days prior to randomization

inclusion criteria: - positive sars-cov-2 diagnostic test (rt-pcr or rapid antigen test)at screening - has symptoms consistent with mild or moderate covid-19, as determined by the investigator, with onset ≤5 days prior to randomization

inclusion criteria: - positive sars-cov-2 diagnostic test (rt-pcr or rapid antigen test)at screening - has symptoms consistent with mild or moderate covid-19, as determined by the investigator, with onset ≤5 days before dosing on day 1

inclusion criteria: - positive sars-cov-2 diagnostic test (rt-pcr or rapid antigen test)at screening - has symptoms consistent with mild or moderate covid-19, as determined by the investigator, with onset ≤5 days before dosing on day 1